Selected hemostatic abnormalities associated with neoplastic disease.
D000990:Antithrombin III / Q000032:analysis; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000209:etiology; D005169:Factor VIII / Q000032:analysis; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D009369:Neoplasms / Q000097:blood*; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors / Q000494:pharmacology; D015849:Plasminogen Inactivators
D005338:Fibrin Fibrinogen Degradation Products; D015849:Plasminogen Inactivators; D000990:Antithrombin III; D005169:Factor VIII; D005340:Fibrinogen; D010960:Plasminogen Activators